Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: neuroscience

Bioviva a Seattle, WA, based biotech is ambitiously moving forward with gene therapy in people to mitigate the consequences of aging. They have not gone for the low hanging fruit either, they are being supported by Maximum Life Foundation to raise enough to run a clinical trial to try to cure Alzheimer’s! They are targeting the supporting Microglia cells in the brain to help regenerate them and hopefully reverse the effects of the disease. A worthy cause if ever I saw one and if it works could translate to other similar conditions like Parkinson’s and ALS. Lets hope they can get this vital work underway. This will then be the first example of regenerative medicine in a person that treats the dysfunction of aging.

Read more

This death penalty story continuing to get coverage. This article below is nice as it mentions another idea I wrote about, which is that of death row prisoners and the possibility of cryonics.

He also suggests putting violent criminals in the Matrix for the rest of their lives.

Read more

Mark Zuckerberg

Advances in the field of artificial intelligence are invariably greeted with concern about an imminent robot uprising. Similarly, when we hear about developments in the field of brain-to-brain communication, we imagine any number of outlandish scenarios: perhaps a government marching us unquestioningly into battle via a process of insidious mind control, or an erotic thought we had about a work colleague being unwittingly transmitted to our partner.

When Facebook’s CEO, Mark Zuckerberg, announced this week during one of his regular Q&A sessions that Facebook is working in the field of thought transmission, we found ourselves momentarily transported to a horrific telepathic future. “You’ll just be able to think of something and your friends will immediately be able to experience it too,” he said, as people thought to themselves “under no circumstances do I want anyone to know the dark, unsettling images that flash through my mind on an hourly basis”. We are troubled by that vision. But it’s only a vision. Read more

Researchers in the US have been testing a new type of antidepressant medication on rats, and say it’s able to treat the symptoms of depression in less than a day, compared to the three to eight weeks it takes current drugs to work. If the results can be replicated in humans, the drug could offer a much more effective option than treatments such as Prozac and Lexapro, which are only effective in only a third of patients who have been diagnosed with depression.

Read more

More interesting developments on the regenerative medicine front this time from UCSF and Villeda. B2M is a downstream consequence of too much TGF-b1 as demonstrated in the recent Conboy regeneration test. This is more validation that cell and tissue regeneration is very near future and should translate to humans.

At UC San Francisco, we are driven by the idea that when the best research, the best teaching and the best patient care converge, we can deliver breakthroughs that help heal the world.

Read more